Untitled

Dr. Routy and Dr. Ancuta co-publish in Retrovirology

May 13, 2015

CanCURE Principal Investigator Dr. Petronela Ancuta (Centre hospitalier de l'Université de Montréal Research Centre) has published a study in Retrovirology with participation of Dr. Jean-Pierre Routy (CanCURE Principal Investigator at the Research Institute of the McGill University Health Centre). Th17 cells represent an important type of CD4+ T-cell that play a role in host defense against microbial pathogens in the gut mucosa. However, progressive HIV infection leads to a loss of mucosal Th17 cells. Through their study, the investigators demonstrate that a shortage of the CD4+ T-cell subsets which are likely to gain Th17 functions is caused, at least in part, by their higher permissiveness to HIV infection. This represents a newly identified mechanism contributing to Th17 deficiency in chronically HIV-infected individuals receiving antiretroviral therapy.

 

(*classified by the journal as Highly Accessed article)

Read the article in Retrovirology >>

 

 Dr. Petronela Ancuta (corresponding author) and Dr. Jean-Pierre Routy

Please reload

CanCURE à la 9e édition de Persistance du VIH pendant la thérapie, Miami, Floride, 2019

December 16, 2019

CanCURE at the 9th Edition of HIV Persistence During Therapy, Miami, Florida, 2019

December 16, 2019

Nouvelle publication du Codirigeant du Thème 2 de CanCURE, Jérôme Estaquier

December 2, 2019

1/2
Please reload

©2019 CanCURE

Follow

  • https://twitter.com/cancurehiv
  • White Facebook Icon
  • White YouTube Icon
  • White LinkedIn Icon